What is ATROB's health score?

ASTRONICS CORP (ATROB) has a TradeApes health score of 51 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ATROB's estimated fair value?

Based on our 5-year discounted cash flow model, ASTRONICS CORP's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is ATROB undervalued or overvalued?

Our model currently rates ATROB as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ATROB... Refresh in a moment for the full analysis.

ASTRONICS CORP (ATROB)

Consumer Cyclical Fair Value High mixed

Updated: 2026-04-21

TradeApes Score

hold

Financial Strength

40 Weak

Operating Trend

60 Healthy

Relative Value

50 Mixed

Capital Allocation

45 Mixed

Risk

70 Healthy

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.